Article Information
History
- May 27, 2020.
Article Versions
- Version 1 (May 26, 2020 - 05:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- 1School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne VIC 3004, Australia
- 2Department of General Medicine, Royal Melbourne Hospital, Grattan St, Parkville VIC 3050, Australia
- 3Monash Bioethics Centre, Monash University, Wellington Rd, Clayton VIC 3800, Australia
- ↵*Correspondence:
Dr George Heriot, School of Public Health and Preventive Medicine, Monash University, Level 4, 553 St Kilda Road, Melbourne VIC 3004, +61 3 9903 0925, george.heriot{at}monash.edu
Posted May 27, 2020.
Tensions between research and public health: modelling the risks and benefits of SARS-CoV-2 vaccine field trials versus human infection challenge studies
